Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study

por Hanzel, Jurij, Jansen, Jeroen M, ter Steege, Rinze W F, Gecse, Krisztina B, D’Haens, Geert R
Publicado 2021

Population dynamics of Hippophae rhamnoides shrub in response of sea-level rise and insect outbreaks

por Decuyper, Mathieu, van den Dool, Robbert, Slim, Pieter A., Kuiters, A. T. (Loek), Jansen, Jeroen M., Sass-Klaassen, Ute
Publicado 2020

Long-term effectiveness and safety of ustekinumab in Crohn’s disease: a prospective cohort study

por Thomas, Pepijn W.A., van Caem, Mark, West, Rachel L., Russel, Maurice G.V.M, Jansen, Jeroen M., Römkens, Tessa E.H., Hoentjen, Frank
Publicado 2022

Geographic and seasonal patterns and limits on the adaptive response to temperature of European Mytilus spp. and Macoma balthica populations

por Jansen, Jeroen M., Pronker, Annelies E., Kube, Sandra, Sokolowski, Adam, Sola, J. Carlos, Marquiegui, Mikel A., Schiedek, Doris, Wendelaar Bonga, Sjoerd, Wolowicz, Maciej, Hummel, Herman
Publicado 2007

Inflammatory bowel disease patients provide reliable self‐reported medical information: A multicentre prospective pharmacovigilance monitoring system

por Thomas, Pepijn W. A., West, Rachel L., Russel, Maurice G. V. M., Jansen, Jeroen M., Kosse, Leanne J., Jessurun, Naomi T., Römkens, Tessa E. H., Hoentjen, Frank
Publicado 2020

Discrepancy between patient‐ and healthcare provider‐reported adverse drug reactions in inflammatory bowel disease patients on biological therapy

por Thomas, Pepijn W. A., Römkens, Tessa E. H., West, Rachel L., Russel, Maurice G. V. M., Jansen, Jeroen M., van Lint, Jette A., Jessurun, Naomi T., Hoentjen, Frank
Publicado 2021

De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation

por Thomas, Pepijn W. A., Smits, Lisa J. T., Te Groen, Maarten, West, Rachel L., Russel, Maurice G. V. M., Jansen, Jeroen M., Römkens, Tessa E. H., Hoentjen, Frank
Publicado 2022

Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study

por Thomas, Pepijn W A, den Broeder, Nathan, Derikx, Monique, Kievit, Wietske, West, Rachel L, Russel, Maurice G V M, Jansen, Jeroen M, Römkens, Tessa E H, Hoentjen, Frank
Publicado 2022

Antimicrobial therapy of 3 days or less is sufficient after successful ERCP for acute cholangitis

por Haal, Sylke, ten Böhmer, Britt, Balkema, Sebastiaan, Depla, Annekatrien CTM, Fockens, Paul, Jansen, Jeroen M, Kuiken, Sjoerd D, Liberov, Boris I, van Soest, Ellert, van Hooft, Jeanin E, Sieswerda, Elske, Voermans, Rogier P
Publicado 2020

Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry

por Giraud, Eline L., Thomas, Pepijn W. A., van Lint, Jette A., van Puijenbroek, Eugene P., Römkens, Tessa E. H., West, Rachel L., Russel, Maurice G. V. M., Jansen, Jeroen M., Jessurun, Naomi T., Hoentjen, Frank
Publicado 2021

Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre...

por Asscher, Vera E. R., Biemans, Vince B. C., Pierik, Marieke J., Dijkstra, Gerard, Löwenberg, Mark, van der Marel, Sander, de Boer, Nanne K. H., Bodelier, Alexander G. L., Jansen, Jeroen M., West, Rachel L., Haans, Jeoffrey J. L., van Dop, Willemijn A., Weersma, Rinse K., Hoentjen, Frank, Maljaars, P. W. Jeroen
Publicado 2020

Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study

por Biemans, Vince B C, van der Meulen - de Jong, Andrea E, van der Woude, Christine J, Löwenberg, Mark, Dijkstra, Gerard, Oldenburg, Bas, de Boer, Nanne K H, van der Marel, Sander, Bodelier, Alexander G L, Jansen, Jeroen M, Haans, Jeoffrey J L, Theeuwen, Rosaline, de Jong, Dirk, Pierik, Marie J, Hoentjen, Frank
Publicado 2020

Vedolizumab for Inflammatory Bowel Disease: Two‐Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registr...

por Biemans, Vince B.C., van der Woude, C. Janneke, Dijkstra, Gerard, van der Meulen‐de Jong, Andrea E., Oldenburg, Bas, de Boer, Nanne K., Löwenberg, Mark, Srivastava, Nidhi, Bodelier, Alexander G.L., West, Rachel L., Jansen, Jeroen M., de Vries, Annemarie C., Haans, Jeoffrey J.L., de Jong, Dirk J., Pierik, Marie J., Hoentjen, Frank
Publicado 2019

Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatment

por Biemans, Vince B. C., van der Woude, C. Janneke, Dijkstra, Gerard, van der Meulen‐de Jong, Andrea E., Löwenberg, Mark, de Boer, Nanne K., Oldenburg, Bas, Srivastava, Nidhi, Jansen, Jeroen M., Bodelier, Alexander G. L., West, Rachel L., de Vries, Annemarie C., Haans, Jeoffrey J. L., de Jong, Dirk, Hoentjen, Frank, Pierik, Marieke J.
Publicado 2020

Treatment of Perianal Fistulas in Crohn’s Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial

por Wasmann, Karin A, de Groof, E Joline, Stellingwerf, Merel E, D’Haens, Geert R, Ponsioen, Cyriel Y, Gecse, Krisztina B, Dijkgraaf, Marcel G W, Gerhards, Michael F, Jansen, Jeroen M, Pronk, Apollo, van Tuyl, Sebastiaan A C, Zimmerman, David D E, Bruin, Karlien F, Spinelli, Antonino, Danese, Silvio, van der Bilt, Jarmila D W, Mundt, Marco W, Bemelman, Willem A, Buskens, Christianne J
Publicado 2020

Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up

por van der Valk, Mirthe E., Mangen, Marie-Josée J., Severs, Mirjam, van der Have, Mike, Dijkstra, Gerard, van Bodegraven, Ad A., Fidder, Herma H., de Jong, Dirk J., van der Woude, C. Janneke, Romberg-Camps, Mariëlle J. L., Clemens, Cees H. M., Jansen, Jeroen M., van de Meeberg, Paul C., Mahmmod, Nofel, van der Meulen-de Jong, Andrea E., Ponsioen, Cyriel Y., Bolwerk, Clemens, Vermeijden, J. Reinoud, Siersema, Peter D., Leenders, Max, Oldenburg, Bas
Publicado 2016

Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry

por Biemans, Vince B. C., Sleutjes, Jasmijn A. M., de Vries, Annemarie C., Bodelier, Alexander G. L., Dijkstra, Gerard, Oldenburg, Bas, Löwenberg, Mark, van Bodegraven, Adriaan A., van der Meulen‐de Jong, Andrea E., de Boer, Nanne K. H., Srivastava, Nidhi, West, Rachel L., Römkens, Tessa E. H., Horjus Talabur Horje, Carmen S., Jansen, Jeroen M., van der Woude, C. Janneke, Hoekstra, Jildou, Weersma, Rinse K., van Schaik, Fiona D. M., Hoentjen, Frank, Pierik, Marieke J.
Publicado 2020

Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life

por Kanis, Shannon Linda, Modderman, Sanne, Escher, Johanna C, Erler, Nicole, Beukers, Ruud, de Boer, Nanne, Bodelier, Alexander, Depla, Annekatrien C T.M, Dijkstra, Gerard, van Dijk, Anne-Baue Ruth Margaretha, Gilissen, Lennard, Hoentjen, Frank, Jansen, Jeroen M, Kuyvenhoven, Johan, Mahmmod, Nofel, Mallant-Hent, Rosalie C, van der Meulen-de Jong, Andrea E, Noruzi, Anahita, Oldenburg, Bas, Oostenbrug, Liekele E, Ter Borg, Pieter C.J., Pierik, Marieke, Romberg- Camps, Mariëlle, Thijs, Willem, West, Rachel, de Lima, Alison, van der Woude, C Janneke
Publicado 2021

Pancreatitis, very early compared with normal start of enteral feeding (PYTHON trial): design and rationale of a randomised controlled multicenter trial

por Bakker, Olaf J, van Santvoort, Hjalmar C, van Brunschot, Sandra, Ali, Usama Ahmed, Besselink, Marc G, Boermeester, Marja A, Bollen, Thomas L, Bosscha, Koop, Brink, Menno A, Dejong, Cornelis H, van Geenen, Erwin J, van Goor, Harry, Heisterkamp, Joos, Houdijk, Alexander P, Jansen, Jeroen M, Karsten, Thom M, Manusama, Eric R, Nieuwenhuijs, Vincent B, van Ramshorst, Bert, Schaapherder, Alexander F, van der Schelling, George P, Spanier, Marcel BM, Tan, Adriaan, Vecht, Juda, Weusten, Bas L, Witteman, Ben J, Akkermans, Louis M, Gooszen, Hein G
Publicado 2011

Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study

por Derikx, Lauranne A A P, Lantinga, Marten A, de Jong, Dirk J, van Dop, Willemijn A, Creemers, Rob H, Römkens, Tessa E H, Jansen, Jeroen M, Mahmmod, Nofel, West, Rachel L, Tan, Adriaan C I T L, Bodelier, Alexander G L, Gorter, Moniek H P, Boekema, Paul J, Halet, Eric R C, Horjus, Carmen S, van Dijk, Maarten A, Hirdes, Meike M C, Epping Stippel, Ludger S M, Jharap, Bindia, Lutgens, Maurice W M D, Russel, Maurice G, Gilissen, Lennard P L, Nauta, Sjoukje, van Bodegraven, Adriaan A, Hoentjen, Frank
Publicado 2020